Skip to content

Eton Pharmaceuticals, Inc. ETON Change in Inventories

Change in Inventories at other companies

HRO
HarrowHROW
$2.97M+21,136%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$185K-9.8%
XER
Xeris Biopharma Holdings, Inc.XERS
-$851K-124%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$4M+300%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$437K-30.1%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$909K

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+162%
Enterprise value$942.39M+156%
P/S10.7×+3.4×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s change in inventories?
Eton Pharmaceuticals, Inc. (ETON) reported change in inventories of -$1.41M in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s change in inventories changed year-over-year?
Eton Pharmaceuticals, Inc.'s change in inventories decreased by 292.7% year-over-year, from -$358K to -$1.41M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.